Abstract |
Although genomic detection is considered the gold standard test on HBV infection identification, the HBsAg investigation is still the most frequent clinical laboratory request to diagnose HBV infection in activity. However, the non-detection of HBsAg in the bloodstream of chronic or acutely infected individuals has been a phenomenon often observed in clinical practice, despite the high sensitivity and specificity of screening assays standardized commercially and adopted in routine. The expansion of knowledge about the hepatitis B virus biology (replication/life cycle, genetic variability/mutability/heterogeneity), their biochemical and immunological properties (antigenicity and immunogenicity), in turn, has allowed to elucidate some mechanisms that may explain the occurrence of this phenomenon. Therefore, the negativity for HBsAg during the acute or chronic infection course may become a fragile or at least questionable result. This manuscript discusses some mechanisms that could explain the negativity for HBsAg in a serological profile of individuals with HBV infection in activity, or factors that could compromise its detection in the bloodstream during HBV infection.
|
Authors | R A A Pondé |
Journal | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
(Eur J Clin Microbiol Infect Dis)
Vol. 34
Issue 9
Pg. 1709-31
(Sep 2015)
ISSN: 1435-4373 [Electronic] Germany |
PMID | 26105620
(Publication Type: Journal Article, Review)
|
Chemical References |
- DNA, Viral
- Hepatitis B Antibodies
- Hepatitis B Surface Antigens
|
Topics |
- Asymptomatic Infections
- DNA, Viral
- Hepatitis B
(diagnosis, virology)
- Hepatitis B Antibodies
(blood)
- Hepatitis B Surface Antigens
(genetics, isolation & purification)
- Hepatitis B virus
(genetics, isolation & purification)
- Humans
|